CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Progression-Free Survival

Length of time during and after the treatment of a disease, such as cancer, that a patient lives with the disease but the disease does not get worse.

Drugs by status

Phase 4 trials (1)

  • brucea javanica

Phase 3 trials (15)

  • doxorubicin
  • fulvestrant
  • paclitaxel
  • lapatinib
  • Filgrastim
  • olanzapine
  • osimertinib
  • carboplatin
  • exemestane
  • bevacizumab
  • anastrozole
  • docetaxel
  • cisplatin
  • etoposide
  • pirarubicin

Phase 2 trials (23)

  • metformin
  • afatinib
  • anlotinib
  • irinotecan
  • fluorouracil
  • imatinib
  • pembrolizumab
  • leucovorin
  • nimotuzumab
  • pemetrexed
  • trastuzumab
  • pertuzumab
  • capecitabine
  • gefitinib
  • gimeracil
  • oteracil
  • oxaliplatin
  • tegafur
  • levoleucovorin
  • camrelizumab
  • savolitinib
  • anrotenib
  • tirelizumab

Other trials (2)

  • lenalidomide
  • ixazomib

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.